Asciminib Roll-over Study
Conditions
Chronic Myelogenous Leukemia · Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Michigan Med University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Moshe Talpaz)Memorial Sloan Kettering, New York, New York, United States
Contact: Principal Investigator (Michael Mauro)Oregon Health Sciences University, Portland, Oregon, United States
Texas Oncology, Dallas, Texas, United States
Contact: Principal Investigator (Moshe Yair Levy)Uni Of TX MD Anderson Cancer Cntr, Houston, Texas, United States
Contact: Principal Investigator (Fadi Haddad)Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Ehab Atallah)Novartis Investigative Site, CABA, Buenos Aires, Argentina
Novartis Investigative Site, Capital Federal, Argentina
Novartis Investigative Site, Graz, Austria
Novartis Investigative Site, Vienna, Austria
Novartis Investigative Site, Rio de Janeiro, Rio de Janeiro, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Varna, Bulgaria
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Chongqing, Chongqing Municipality, China
Novartis Investigative Site, Guangzhou, Guangdong, China
Novartis Investigative Site, Zhengzhou, Henan, China
Novartis Investigative Site, Wuhan, Hubei, China
Novartis Investigative Site, Changchun, Jilin, China
Novartis Investigative Site, Xian, Shanxi, China
Novartis Investigative Site, Chengdu, Sichuan, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Beijing, China
Novartis Investigative Site, Shanghai, China
Novartis Investigative Site, Shenyang, China
Novartis Investigative Site, Tianjin, China
Novartis Investigative Site, Ostrava, Poruba, Czechia
Novartis Investigative Site, Brno, Czechia
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Bordeaux, France
Novartis Investigative Site, Lyon, France
Novartis Investigative Site, Marseille, France
Novartis Investigative Site, Nantes, France
Novartis Investigative Site, Paris, France
Novartis Investigative Site, Vandœuvre-lès-Nancy, France
Novartis Investigative Site, Frankfurt am Main, Hesse, Germany
Novartis Investigative Site, Jena, Thuringia, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Kiel, Germany
Novartis Investigative Site, Milan, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Naples, Italy
Novartis Investigative Site, Kobe, Hyōgo, Japan
Novartis Investigative Site, Beirut, Lebanon
Novartis Investigative Site, George Town, Pulau Pinang, Malaysia
Novartis Investigative Site, Johor Bahru, Malaysia
Novartis Investigative Site, Kuala Selangor, Malaysia
Novartis Investigative Site, Monterrey, Nuevo León, Mexico
Novartis Investigative Site, Khoudh, Oman
Novartis Investigative Site, Katowice, Poland
Novartis Investigative Site, Krakow, Poland
Novartis Investigative Site, Warsaw, Poland
Novartis Investigative Site, Wroclaw, Poland
Novartis Investigative Site, Lisbon, Portugal
Novartis Investigative Site, Porto, Portugal
Novartis Investigative Site, Timișoara, Romania
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Saint Petersburg, Russia
Novartis Investigative Site, Saint Petersburg, Russia
Novartis Investigative Site, Riyadh, Saudi Arabia
Novartis Investigative Site, Singapore, Singapore
Novartis Investigative Site, Uijeongbu-si, Gyeonggi-do, South Korea
Novartis Investigative Site, Busan, South Korea
Novartis Investigative Site, Jeollanam, South Korea
Novartis Investigative Site, Seoul, South Korea
Novartis Investigative Site, Santiago Compostela, A Coruna, Spain
Novartis Investigative Site, Badalona, Barcelona, Spain
Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, Spain
Novartis Investigative Site, Bilbao, Bizkaia, Spain
Novartis Investigative Site, Santa Cruz, Santa Cruz De Tenerife, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Barcelona, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Seville, Spain
Novartis Investigative Site, Valencia, Spain
Novartis Investigative Site, Taoyuan, Taiwan
Novartis Investigative Site, Samsun, Atakum, Turkey (Türkiye)
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, Oxford, United Kingdom
Novartis Investigative Site, Hanoi, Vietnam
Novartis Investigative Site, Ho Chi Minh City, Vietnam
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals